P13.02 Conventional MRI radiomics in the diagnosis of early- and pseudo-progression

BACKGROUND: After radiochemotherapy, 20% to 30% of patients with early worsening MRI experience pseudoprogression (Psp) which is not distinguishable from early progression (EP). We aimed to assess the diagnostic performance and survival predictive ability of radiomics in patients with suspected EP o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Bani Sadr, A, Eker, O F, Berner, L, Ameli, R, Hermier, M, Barritault, M, Meyronet, D, Guyotat, J, Jouanneau, E, Honnorat, J, Ducray, F, Berthezène, Y
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Poster Presentations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796042/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.223
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items